碳氧血球蛋白是治疗败血症和败血症休克患者的有效床边预后工具吗?
Bianca-Liana Grigorescu1, Oana Coman2, Anca Meda Văsieșiu3
1Department of Anesthesia and Intensive Care, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania.
这项研究发现患者的败血症严重程度得分 (SOFA,APACHE II,SAPS II) 之间存在强烈的相关性. 虽然中性细胞-淋巴细胞比率和碳氧血红蛋白没有显示任何相关性,但这些验证的得分可能有助于预测败血症的结果.
科学领域:
- 关键护理医学 关键护理医学
- 生物标志物 生物标志物
- 预测工具 预测工具
背景情况:
- 败血症的管理需要早期诊断和有效的治疗.
- 需要具有成本效益的床边工具来预测败血症和败血症休克的结果.
研究的目的:
- 调查已建立的败血症严重程度得分 (SOFA,APACHE II,SAPS II) 和新生物标志物 (NLR,COHb) 之间的相关性.
- 评估这些参数作为毒症和败血症休克病例的病床预后工具的潜力.
主要方法:
- 一项试点,前性,观察性研究包括61名败血症或败血性休克患者.
- 在第一天和第五天评估了临床和准临床参数,包括SOFA,APACHE II,SAPS II,NLR和COHb.
主要成果:
- 在第1天和第5天,所有严重程度得分 (SOFA,APACHE II,SAPS II) 之间观察到显著的正相关性.
- 严重性得分与中性粒细胞-淋巴细胞比率或碳氧血红蛋白水平之间没有显著的相关性.
结论:
- 已确定的败血症严重程度得分有很强的相关性,这表明它们的联合使用用于预后.
- 需要进一步的研究来确定可靠的,具有成本效益的临床预后工具来治疗败血症和败血症休克.
更多相关视频
07:51Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
Published on: May 21, 2019
14:28Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
Published on: May 10, 2024
相关概念视频
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Oxygen Transport in the Blood
